Diagnostic Classifier for Cutaneous T-cell Lymphomas
试验速览
- 阶段
- 不适用
- 入组人数
- 160
- 试验地点
- 1
- 主要终点
- Proteomic signature of MF in comparison to eczema, psoriasis, and healthy control skin
研究概览
简要总结
Primary cutaneous T-cell lymphomas (CTCL) are a form of skin cancer that is derived from immune cells. The most common form of CTCL is mycosis fungoides (MF). While initially confined to the skin, MF may spread to lymph nodes, blood or inner organs, resulting in an overall poor prognosis for the patient. Thus, being a potentially lethal disease, an early and correct diagnosis of MF has very important implications for the patient. However, diagnosis of early MF is often difficult, as it usually shows a close resemblance to benign inflammatory conditions such as eczema and psoriasis. Strikingly, it takes an average of 3-6 (!) years from the appearance of the first skin lesions until a diagnosis of MF can be made. For this reason, a test to distinguishing early MF from benign inflammatory conditions is urgently mandated. By using skin suction blister fluid as well as skin biopsies from patients with MF, eczema and psoriasis, the investigators want to develop a classifier system that can distinguish early MF from benign inflammatory skin diseases.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 100 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical and/or histopathological diagnosis of MF, eczema or psoriasis
- •Healthy control subjects without personal history of MF, eczema or psoriasis
排除标准
- •Ongoing skin-targeted treatment (Wash out times: 2 weeks for topical, and 4 weeks for systemic treatments)
- •Ongoing other treatment that might, in the opinion of the investigator, influence proteomic features of the samples to be acquired
结局指标
主要结局
Proteomic signature of MF in comparison to eczema, psoriasis, and healthy control skin
时间窗: At baseline
Proteomic multiplex assay
次要结局
未报告次要终点
研究者
Patrick M. Brunner
Associate Professor
Medical University of Vienna
